P7170, a novel inhibitor of phosphoinositide 3-kinase (PI3K)-mammalian target of Rapamycin (mTOR) and activin receptor-like kinase 1 (ALK1) as a new therapeutic option for Kras mutated non small cell lung cancer (NSCLC)
- Resource Type
- Journal
- Source
CANCER RESEARCH ; APR 15 2012, 72 2p. Supplement: 8- Subject
- Language
- English
- ISSN
- 15387445